Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001628280-23-006991)

Filing Details

Accession Number:: 0001628280-23-006991
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-08 16:21:24
Reporting Period:: 2023-03-07

Accepted Time:: 2023-03-08 16:21:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434868	Esperion Therapeutics Inc.	ESPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1766524	L. Sheldon Koenig	C/O Esperion Therapeutics, Inc. 3891 Ranchero Drive, Suite 150 Ann Arbor MI 48108	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-07	5,441	$5.06	194,815	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.
Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan.